Business Standard

There will be a coronavirus vaccine, likely by 2022-end: Zavaray Poonawalla

Founder-Director Serum Institute of India tells Business Standard that India's social containment of the epidemic so far has been good

Zavaray Poonawalla
Premium

Zavaray Poonawalla, Founder-Director Codagenix

Pavan Lall
Serum Institute of India recently partnered Codagenix, a US-based biotech drug research company, to develop a coronavirus (COVID-19) vaccine. Its Founder-Director Zavaray Poonawalla tells Business Standard that India’s social containment of the epidemic so far has been good. Edited Excerpts: 

How is India doing as far as managing the whole social community distancing factor goes, with the advent of the COVID-19? Are our numbers of confirmed cases being under-reported?

I think we are taking it very seriously and perhaps that’s a good thing in a country with the size of our population. In practical terms, people are avoiding crowds, flights

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in